Breast Cancer Clinical Trials in Suwon, Gyeonggi-do
2 recruitingSuwon, Gyeonggi-do, South Korea
Showing 1–2 of 2 trials
Recruiting
Phase 3
OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
Breast CancerMetastatic Breast CancerAdvanced Breast Cancer+1 more
Olema Pharmaceuticals, Inc.510 enrolled233 locationsNCT06016738
Recruiting
A Post Marketing Surveillance on Piqray in Korea
Breast Cancer
Novartis Pharmaceuticals900 enrolled17 locationsNCT05293470